V6, as discussed in detail earlier, if Kenactiv has ongoing revenues, i don't expect the new entity to trade like a typical revenue-less pink stock.
a 160k sq ft facility implies significant production capacity.
far more than the desk in mom's basement of most pink companies that trade on hype alone.
as before, if we have 1b shares issued, and were trading in the normal pink 000x-00xx range, i could see strong pink runs (10x-20x) on hype alone, as you suggest.
but, imo, there's a psyche factor for pink stocks trading over $1.
viz, how likely would you be to pay $8 for a running pink stock you knew nothing about, but was the hot momo play of the day?
0008 with momo, sure.
but an $8 pink?
thus my logic that >$4 range will be tough to reach without solid financials and net profit driving P/E math.
for ref, pre-split pricing:
$2.50 OPHID == 0.05 pre-split OPHI, way underwater for most here.
$4 OPHID == 0.08 pre-split OPHI, probably break-even to small profit for those who avg'd down.
$10 OPHID == 0.20 pre-split OPHI highs from last spring
note that $2.50/share is $140m market cap.
which would be merited by $10m-20m in annual net profit.
and $10/share is $560m market cap.
which would be merited by $35m-70m in annual net profit.
both ranges being steep for an emerging company.
thus my sense that we got reamed in the RS.
time will tell, as it always does...
News 
Market Data 
Discover 
